Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure

Annals of Internal Medicine

Volumn 132, Issue 7, 2000, Pages 525-532

  Cavicchi, Maryan ^a   Beau, Philippe ^a   Crenn, Pascal ^a   Degott, Claude ^a   Messing, Bernard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHILD; CHOLESTASIS; COHORT ANALYSIS; CONTROLLED STUDY; ENTEROPATHY; FEMALE; HOME CARE; HUMAN; LIVER DISEASE; LIVER FUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PARENTERAL NUTRITION; PREVALENCE; PRIORITY JOURNAL;

EID: 0034603773     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-132-7-200004040-00003     Document Type: Article

References (59)

1. Quigley EM, Marsh MN, Shaffer JL, Markin RS. Hepatobiliary complications of total parenteral nutrition. Gastroenterology. 1993;104: 286-301.
2. Clarke PJ, Ball MJ, Kettlewel MG. Liver function tests in patients receiving parenteral nutrition. JPEN J Parenter Enteral Nutr. 1991;15:54-9.
3. Bowyer BA, Fleming CR, Ludwig J, Petz J, McGill DB. Does long-term home parenteral nutrition in adult patients cause chronic liver disease? JPEN J Parenter Enteral Nutr. 1985;9:11-7.
4. Messing B, Colombel JF, Heresbach D, Chazouillères O, Galian A. Chronic cholestasis is related to macronutrient excess in patients treated with prolonged parenteral nutrition. Nutrition. 1992;8:30-6.
5. Stanko RT, Nathan G, Mendelow H, Adibi SA. Development of hepatic cholestasis and fibrosis in patients with massive loss of intestine supported by prolonged parenteral nutrition. Gastroenterology. 1987;92:197-202.
6. Ito Y, Shils ME. Liver dysfunction associated with long-term total parenteral nutrition in patients with massive bowel resection. JPEN J Parenter Enterai Nutr. 1991;15:271-6.
7. Messing B, Zarka Y, Lémann M, Iglicki F, Coffin B, Rambaud JC. Chronic cholestasis associated with long-term parenteral nutrition [Abstract]. Transplant Proc. 1994;26:1438-9.
8. Cano N, Messing B. Conséquences hépatiques et biliaires de la nutrition artificielle. Nutr Clin Métabol. 1994;8:149-62.
9. van Deventer SJ, ten Cate JW, Tytgat GN. Intestinal endotoxemia. Clinical significance. Gastroenterology. 1988;94:825-31.
10. Beau P, Barrioz T, Ingrand P. Total parenteral nutrition-related cholestatic hepatopathy, is it an infectious disease? [L'hépatopathie cholestatique de la nutrition parentérale totale est-elle une maladie infectieuse?] Gastroenterol Clin Biol. 1994;18:63-7.
11. Messing B, Lémann M, Landais P, Gouttebel MC, Gerard-Boncompain M, Saudin F, et al. Prognosis of patients with nonmalignant chronic intestinal failure receiving long-term home parenteral nutrition. Gastroenterology. 1995;108:1005-10.
12. Peden VH, Witzleben CL, Skelton MA. Total parenteral nutrition [Letter]. J Pediatr. 1971;78:180-1.
13. Craig RM, Neumann T, Jeejeebhoy KN, Yokoo H. Severe hepatocellular reaction resembling alcoholic hepatitis with cirrhosis after massive small bowel resection and prolonged total parenteral nutrition. Gastroenterology. 1980;79:131-7.
14. Grant D. Intestinal transplantation: 1997 report of the International Registry. Intestinal Transplant Registry. Transplantation. 1999;67:1061-4.
15. Brousse N, Goulet O. Small bowel transplantation [Editorial]. BMJ. 1996; 312:261-2.
16. Quigley EM. Small intestinal transplantation: reflections on an evolving approach to intestinal failure. Gastroenterology. 1996;110:2009-12.
17. Messing B, Crenn P, Beau P, Boutron-Ruault MC, Rambaud JC, Matuchansky C. Long-term survival and patenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology. 1999;117:1043-50.
18. Nanji AA, Anderson FH. Sensitivity and specificity of liver function tests in the detection of parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr. 1985,9:307-8.
19. Degott C, Messing B, Moreau D, Chazouillères O, Paris R, Colombel JF, et al. Liver phospholipidosis induced by parenteral nutrition: histologic, histochemical, and ultrastructural investigations. Gastroenterology. 1988;95: 183-91.
20. Harris JA, Benedict FG. A biometric study of basal metabolism in man Washington, DC: Carnegie Institute of Washington; 1919.
21. Tkoub M, Crenn P, Cohen-Solal M, de Vernejoul MC, Messing B. Role of parenteral nutrition in bone, lean and fat mass variations during intestinal malabsorption syndrome [Abstract]. Clin Nutr. 1997;16(Suppl 1).32.
22. Kaplan EL, Meier P. Non-parametric estimation for incomplete observations. Journal of the American Statistical Association. 1958;53:457-81.
23. Cox DR, Snell EJ. Analysis of Binary Data. 2d ed. London: Chapman & Hall; 1989.
24. Peto R, Pike MC, Armitage P. Design and analysis of randomised trials requiring prolonged observations of each patient. Br J Cancer. 1977;35:1-39.
25. Tabachnik BG, Fidele LF. Using Multivariate Statistics. New York: Harper and Row; 1983.
26. Dahms BB, Halpin TC. Serial liver bioosies in parenteral nutrition-associated cholestasis of early infancy. Gastroenterology. 1981;81:136-44.
27. Wolfe BM, Walker BK, Shaul DB, Wong L, Ruebner BH. Effect of total parenteral nutrition on hepatic histology. Arch Surg. 1988;123:1084-90
28. Messing B, de Oliveira FJ, Galian A, Bernier JJ. Cholestasis during total parenteral nutrition: demonstration of facilitating factors, association with gallbladder lithiasis [Cholestase au cours de la nutrition parentérale totale: mise en évidence de facteurs favorisants; association à une lithiase vésiculaire]. Gastroenterol Clin Biol. 1982;6:740-7.
29. Mughal M, Irving MH. Home parenteral nutrition in the United Kingdom and Ireland. Lancet. 1986;328:383-7.
30. Burnes JA, O'Keefe SJ, Fleming RC, Devine RD, Berkner S, Herrick L. Home parenteral nutrition - a 3-year analysis of clinical and laboratory monitoring. JPEN J Parenter Enteral Nutr. 1992;16:327-32.
31. Benjamin DR. Hepatobiliary dysfunction in infants and children associated with long-term total parenteral nutrition. A clinico-pathologic study. Am J Clin Pathol. 1981;76:276-83.
32. Drongowski RA, Coran AG. An analysis of factors contributing to the development of total parerteral nutrition-induced cholestasis. JPEN J Parenter Enteral Nutr. 1989;13:586-9.
33. Beau P, Labat-Labourdette J, Ingrand P, Beauchant M. Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease? J Hepatol. 1994;20:240-4.
34. Spagnuolo MI, Iorio R, Vegnente A, Guarino A. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition a pilot study. Gastroenterology. 1996;111:716-9.
35. Guertin F, Roy CC, Lepage G, Perea A, Giguère R, Yousef I, et al. Effect of taurine on total parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr. 1991;15:247-51.
36. Belli DC, Fournier LA, Lepage G, Yousef I, Weber AM, Tuchweber B, et al. Total parenteral nutrition-associated cholestasis in rats: comparison of different amino acid mixtures. JPEN J Parenter Enteral Nutr. 1987;11:67-73.
37. Fouin-Fortunet H, Le Quernec L, Erlinger S, Lerebours E, Colin R. Hepatic alterations during total parenteral nutrition in patients with inflammatory bowel disease: a possible consequence of lithocholate toxicity. Gastroerterology. 1982;82:932-7.
38. Crenn P, Matuchansky C, Messing B. Clinical and biochemical modelization of post-surgical intestinal failure in human adults. Clin Nutr. 1997;16:133-5.
39. Allardyce DB. Cholestasis caused by lipid emulsions. Surg Gynecol Obstet 1982;154:641-7.
40. Gerard-Boncompain M, Claudel JP, Gaussorgues P, Salord F, Sirodot M, Chevallier M, et al. Hepatic cytolytic and cholestatic changes related to a change of lipid emulsions in four long-term parenteral nutrition patients with short bowel. J Parenter Enteral Nutr. 1992;16:78-83.
41. Clayton PT, Bowron A, Mills KA, Massoud A, Casteels M, Milla PJ. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology. 1993;105:1806-13.
42. Messing B, Peynet J, Poupon J, Pfeiffer A, Thuillier F, Chazouilléres O, et al. Effect of fat-emulsion phospholipids on serum lipoprotein profile during 1 mo of cyclic total parenteral nutrition. Am J Clin Nutr. 1990;52:1094-100.
43. Kaminski DL, Adams A, Jellinek M. The effect of hyperalimentation on hepatic lipid content and lipogenic enzyme activity in rats and man. Surgery 1980;88:93-100.
44. Martinez M, Ballabriga A. Effects of parenteral nutrition with high doses of linoleate on the developing human liver and brain Lipids. 1987;22:133-8.
45. Levecq H, Lageron A, Gotheil C, Callard P, Beaugrand M. Hepatic lipid overload in 2 cases of cholestasis associated with patenterai feeding [Etude de la surcharge lipidique hépatique au cours de deux cas de cholestase associée à la nutrition parentérale]. Gastroenterol Clin Biol. 1988;12:691-6.
46. Smit JJ, Schinkel AH, Oude Elferink RP, Groen AK, Wagenaar E, van Deemter L, et al. Homozygous disruption of the murine mdr-2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell. 1993;75:451-62.
47. van den Bosch H, Schutgens RB, Wanders RJ, Tager JM. Biochemistry of peroxisomes. Annu Rev Biochem. 1992;61:157-97.
48. Forbush B, Kiristioglu I, Teitelbaum DH, Eisenbraun MD. Heidelberg KP. Multi-drug resistance 2 gene expression in the murine liver: relevance to the development of parenteral nutrition-associated cholestasis [Abstract]. Gastroenterology. 1998;114(Suppl):124.
49. Trauner M, Arrese M, Soroka CJ, Ananthanarayanan M, Koeppel TA, Schlosser SF, et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997;113:255-64.
50. Piquette-Miller M, Pak A, Kim H, Shahzamani A. Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation. Pharm Res. 1998;15:706-11.
51. Van Nieuwkerk CM, Elferink RP, Groen AK, Ottenhoff R, Tytgat GN, Dingemans KP, et al. Effects of ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. Gastroenterology. 1996;111:165-71.
52. Kono K, Ohnishi K, Omata M, Saito M, Nakayama T, Hatano H, et al. Experimental portal fibrosis produced by intraportal injection of killed non-pathogenic Escherichia cali in rabbits. Gastroenterology. 1988;94:787-96.
53. Gogos CA, Zoumbos NC, Makri M, Kalfarentzos F. Tumor necrosis factor production by human mononuclear cells during total parenteral nutrition containing long-chain triglycerides. Nutrition. 1992;8:26-9.
54. Roth B, Fkelund M, Fan BG, Hagerstrand I, Nilsson-Ehle P. Lipid deposition in Kupffer cells after parenteral fat nutrition in rats: a biochemical and ultrastructural study. Intensive Care Med. 1996;22:1224-31.
55. Fischer GW, Hunter KW, Wilson SR, Mease AD. Diminished bacterial defenses win. Intralipid. Lancet. 1980;2:819-20.
56. Capron JP, Gineston JL, Hervé MA, Braillon A. Metronidazole in prevention of cholestasis associated with total parenteral nutrition. Lancet. 1983;1:446-7.
57. Lambert JR, Thomas SM. Metronidazole prevention of serum liver enzyme abnormalities during total parenteral nutrition. JPEN J Parenter Enteral Nutr. 1985;9:501-3.
58. Scott-Conner CE, Grogan JB. The pathophysiology of biliary obstruction and its effect on phagocytic and immune function. J Surg Res. 1994;57:316-36.
59. Innes GK, Nagafuchi Y, Fuller BJ, Hobbs KE. Increased expression of major histocompatibility antigens in the liver as a result of cholestasis. Transplantation. 1988;45:749-52.